Tuesday, July 12, 2022
10:36 AM EST – Knight Therapeutics Inc. : Announced today acceptance by the Toronto Stock Exchange of the Company’s Notice of Intention to Make a Normal Course Issuer Bid. Pursuant to the NCIB, the Company proposes to purchase, from time to time over the next 12 months, if considered advisable, up to 7,988,986 common shares of the Company, being approximately 10% of its public float of 79,889,867 common shares, as of June 30..As of June 30, there were a total of 114,623,079 common shares issued and outstanding. Purchases may commence on July 14, 2022 and will conclude on the earlier of the date on which purchases under the bid have been completed and July 13, 2023. Knight Therapeutics Inc. (T.GUD) shares were down $0.02 at 5.36.
Stocks in Play: Knight Therapeutics Inc., Tue, 12 Jul 2022 10:42:07 EST